IMMUNOCYTOCHEMICAL LOCALIZATION OF CYSTEINE SULFINATE DECARBOXYLASE IN ASTROCYTES IN THE CEREBELLUM AND HIPPOCAMPUS - A QUANTITATIVE DOUBLEIMMUNOFLUORESCENCE STUDY WITH GLIAL FIBRILLARY ACIDIC PROTEIN AND S-100 PROTEIN
I. Reymond et al., IMMUNOCYTOCHEMICAL LOCALIZATION OF CYSTEINE SULFINATE DECARBOXYLASE IN ASTROCYTES IN THE CEREBELLUM AND HIPPOCAMPUS - A QUANTITATIVE DOUBLEIMMUNOFLUORESCENCE STUDY WITH GLIAL FIBRILLARY ACIDIC PROTEIN AND S-100 PROTEIN, Neuroscience, 75(2), 1996, pp. 619-633
Immunocytochemistry of cysteine sulfinate decarboxylase was performed
with a new rabbit antiserum that we have recently produced and charact
erized using as antigen an 11,000-fold purified fraction isolated from
rat liver. This antiserum precipitated cysteine sulfinate decarboxyla
se enzymatic activity, labeled one band (mol, wt 51,000) on immunoblot
s of crude tissue extracts and did not stain any cells in peripheral t
issues devoid of cysteine sulfinate decarboxylase. According to these
criteria, this antiserum appeared to be specific for cysteine sulfinat
e decarboxylase. Numerous cells were immunolabeled in the cerebellum a
nd the hippocampus. Most notable was the labeling of the small cells s
urrounding the Purkinje cells and sending radial fibers up to the pial
surface of the cerebellar cortex or the staining of small star-shaped
cells with thin immunolabeled processes abutting on blood vessels. Id
entified nerve cells such as the Purkinje cells and granule cells in t
he cerebellum or the pyramidal and granule cells in the hippocampus we
re devoid of any immunoreactivity. Simultaneous double immunofluoresce
nce was carried out using anti-glial fibrillary acidic protein or anti
-S-100 monoclonal antibodies. Cysteine sulfinate decarboxylase as well
as glial fibrillary acidic protein- or S-100-immunopositive cells wer
e plotted independently for the same section. Quantitative analysis of
the maps indicated that the overwhelming majority of cysteine sulfina
te decarboxylase-immunolabeled cells were positive for the established
astrocytes markers, glial fibrillary acidic protein or S-100. Between
82 and 98% of cysteine sulfinate decarboxylase-immunolabeled cells we
re also glial fibrillary acidic protein-positive, depending upon the l
ayer. Cysteine sulfinate decarboxylase immunostaining was localized wi
thin the cytoplasm, while that of glial fibrillary acidic protein was
linked to the cytoskeleton. Since both labels could not be fully super
posed, some double immunolabeled cells may have escaped our analysis.
More than 94% up to 99% of cysteine sulfinate decarboxylase-immunolabe
led cells were simultaneously S-100-immunopositive. Our quantitative d
ata establish that cysteine sulfinate decarboxylase is strictly locali
zed in astrocytes in the cerebellum and in the hippocampus. This findi
ng suggest that taurine is synthesized by astrocytes in the brain and
accordingly may play a role in relation to glial function, possibly wi
thin the framework of glial-neuronal interactions. Copyright (C) 1996
IBRO.